Pharmacological considerations on cycloserine.
D000409:Alanine / Q000037:antagonists & inhibitors; D000818:Animals; D001419:Bacteria / Q000187:drug effects; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D002473:Cell Wall / Q000187:drug effects* / Q000201:enzymology; D003523:Cycloserine / Q000378:metabolism* / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D006168:Guinea Pigs; D000882:Haplorhini; D007535:Isomerases / Q000037:antagonists & inhibitors; D008025:Ligases / Q000037:antagonists & inhibitors; D051379:Mice; D008970:Molecular Weight; D011817:Rabbits
D003523:Cycloserine; D002262:Carboxy-Lyases; D007535:Isomerases; D008025:Ligases; D000409:Alanine